Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
R&D
Podcast
Ipsen R&D chief on pipeline discipline and 2026 milestones
Christelle Huguet, Ph.D., Ipsen’s EVP and head of R&D, explains why she sees the biopharma as an “accelerator” of innovation.
Ayla Ellison
Jun 12, 2026 9:57am
Novartis trims ‘select number’ of biomedical research roles
May 15, 2026 10:58am
Takeda ends mRNA research pact with Japanese drug discoverer
Apr 14, 2026 9:57am
J&J, Royalty to co-fund $500M autoimmune antibody program
Mar 30, 2026 10:07am
Top 10 pharma R&D budgets of 2025
Mar 30, 2026 3:00am
Fierce Pharma
Novartis pledges nearly $480M to bolster China production, R&D
Mar 23, 2026 10:35am
